Omega Funds has announced the successful close of its eighth flagship fund, raising $647 million to back life sciences startups focused on tackling serious, unmet medical needs. The fund slightly trailed the $650 million raised in its previous round in 2021, but still exceeded its internal target of $600 million—thanks to strong backing from both longstanding supporters and new limited partners. Continue reading Omega Funds Closes $647 Million Biotech Fund Despite Industry Slowdown →